A one-day workshop was organised by our EVAg partner Animal and Plant Health Agency, APHA on the 15th of October, 2016. The aim of this workshop was t... read more
global Non-profit organisation for sharing viral material within the scientific community
EVAg is an open entity aiming at developing synergies and complementary capabilities
EVAg provides you with high quality viruses and derived products
EVAg is a non profit organisation that mobilises a global network with expertise in virology to collect amplify characterise standardise authenticate distribute track viruses and derived products.
A unique biological resource in the field of virology, readily available online. Users may benefit from special funding to access to products of interest, do not hesitate to apply.
A network of laboratories
An international group of 25 laboratories, including 16 EU member state institutions and 9 non-EU institutions, that represent an extensive range of virological disciplines.
An open entity aiming at developing synergies and complementary capabilities in such a way as to offer an improved access to researchers.
The quality of viruses and derived products is a key consideration when our products are to be made available. Improvements on quality process will be addressed during the project.
Preparedness and Response
EVAg generates and distributes globally diagnostic materials and protocols in the event of epidemiological emergencies.
Focused on the creation of new tools, techniques and concepts to develop the infrastructure and to provide easier and less expensive access to virological materials.
A user-friendly web Portal with a continuously increasing number of viruses and derived products. Start here...
The EVAg initiative will increase competitiveness and, provides for a strong interaction with industry and a promising foundation for the innovation process between academia and industry.- The European Commission -
The initiative has an important social impact with particular emphasis on human disease.- The European Commission -
The quality of the installations cooperating in this consortium is excellent, representing some of the best available infrastructures across the EU and world-wide.- The European Commission -
Our Latest Tweets
Interesting new perspective on #Alzheimer disease and #Herpesvirus: Aβ binds and agglutinates HSV1 and HHV6 viruses. Read the first paper too, from Readhead et al. You can access our collection of HSV1 and HHV6 viruses via our catalogue: https://t.co/3RYHEwboi2 https://t.co/NxOKWyKcJf